LeMaitre earnings: what to look for from LMAT

What happened

LeMaitre Vascular, a medical device company, will report earnings on Wednesday after the market closes. Last quarter it missed analysts' revenue expectations, posting $70.38 million in revenue, up 9.6% year on year. This quarter, the market expects revenue to grow 10.4% year on year.

Confirmed

Global impact / market context

Investors will compare results with the 10.4% revenue growth expectation, which means the projected yearly sales increase. A shortfall could weaken confidence because LeMaitre has missed revenue estimates several times over the past two years, while a match or beat would support the view that demand is holding steady.

Analyst inference

Other healthcare equipment companies have already reported mixed results: Intuitive Surgical grew revenue 21.7%, while Integra LifeSciences grew 2.3%. These figures give a reference point for judging whether LeMaitre's expected 10.4% growth is in line with, above, or below what similar companies are delivering this quarter.

Analyst inference

What to watch

1. Watch whether reported revenue reaches the 10.4% year-on-year growth the market expects, after last quarter's 9.6% growth and revenue miss of $70.38 million. Confirmed
2. Analysts have reconfirmed their estimates over the last 30 days, which suggests they expect the business to stay the course; any guidance change would challenge that assumption. Proposed
3. Compare LeMaitre's growth with peers like Intuitive Surgical's 21.7% and Integra's 2.3%; a weak result could reduce investor confidence in the stock. Analyst inference

Evidence

• stockstory.org